| Zacks Company Profile for LifePoint Inc. (LFPI : OTC) |
|
|
| |
| • Company Description |
| Lifepoint, Inc. (formerly known as South Carolina Organ Procurement Agency, Inc.), an organ procurement organization, provides organ recovery services in South Carolina. Its organ recovery services include organ recovery and hospital development and tissue recovery services include tissue recovery, ocular distribution and case management, and communications center. LifePoint, Inc. is a development stage company focused on the commercialization of the flow immune sensor technology licensed from the Naval Research Laboratories. This technology, when used in conjunction with saliva as a non-invasive test specimen using the Company's collection technology, will allow LifePoint to develop a non-invasive, rapid, on-site diagnostic test system. The company also provides professional and public education regarding organ donations, and educational and emotional support to families of donors. It offers organ, eye, tissue, and ocular donor services to various hospitals.
Number of Employees: |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $ |
Daily Weekly Monthly
 |
| 20 Day Moving Average: shares |
| Shares Outstanding: (millions) |
| Market Capitalization: $ (millions) |
| Beta: |
| 52 Week High: $ |
| 52 Week Low: $ |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
% |
% |
| 12 Week |
% |
% |
| Year To Date |
% |
% |
|
|
|
|
| |
| • Address & Contact Information |
| Street Address |
Phone / Fax |
Email Address |
Web URL |
1205 S. DUPONT ST.
-
ONTARIO,A6 91761
- |
ph: 909-418-3052
fax: 909-418-3003 |
None |
http://www.lifepoint-sc.org |
|
|
| |
| • General Corporate Information |
Officers
Linda H. Masterson - Principal Executive Officer & Director
Craig S. Montesanti - Principal Financial Officer
Nuno Brandolini - Director
William A. Cavendish - Director
Peter S. Gold - Director
|
|
Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 53215R100
SIC: 3841
|
|
Fiscal Year
Fiscal Year End: March
Last Reported Quarter: -
Next Expected EPS Date: -
|
|
Share - Related Items
Shares Outstanding:
Most Recent Split Date: (:1)
Beta:
Market Capitalization: $ (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: % |
| Current Fiscal Quarter EPS Consensus Estimate: $ |
Indicated Annual Dividend: $0.00 |
| Current Fiscal Year EPS Consensus Estimate: $ |
Payout Ratio: |
| Number of Estimates in the Fiscal Year Consensus: |
Change In Payout Ratio: |
| Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
| Next EPS Report Date: - |
|
|
|
| |
